Advances in the Molecular Landscape of Lung Cancer Brain Metastasis

• Main Author: Souza, Vanessa G. P. [UNESP]
• Publication Date: 2023
• Other Authors: de Araújo, Rachel Paes [UNESP], Santesso, Mariana R. [UNESP], Seneda, Ana Laura [UNESP], Minutentag, Iael W. [UNESP], Felix, Tainara Francini [UNESP], Hamamoto Filho, Pedro Tadao [UNESP], Pewarchuk, Michelle E., Brockley, Liam J., Marchi, Fábio A., Lam, Wan L., Drigo, Sandra A. [UNESP], Reis, Patricia P. [UNESP]
• Format: Other
• Language: eng
• Source: Repositório Institucional da UNESP
• Download full: http://dx.doi.org/10.3390/cancers15030722; http://hdl.handle.net/11449/248346
• topic: brain metastasis; coding and non-coding RNAs; lung cancer; microenvironment; molecular mechanisms; therapeutic strategies

Lung cancer is one of the most frequent tumors that metastasize to the brain. Brain metastasis (BM) is common in advanced cases, being the major cause of patient morbidity and mortality. BMs are thought to arise via the seeding of circulating tumor cells into the brain microvasculature. In brain tissue, the interaction with immune cells promotes a microenvironment favorable to the growth of cancer cells. Despite multimodal treatments and advances in systemic therapies, lung cancer patients still have poor prognoses. Therefore, there is an urgent need to identify the molecular drivers of BM and clinically applicable biomarkers in order to improve disease outcomes and patient survival. The goal of this review is to summarize the current state of knowledge on the mechanisms of the metastatic spread of lung cancer to the brain and how the metastatic spread is influenced by the brain microenvironment, and to elucidate the molecular determinants of brain metastasis regarding the role of genomic and transcriptomic changes, including coding and non-coding RNAs. We also present an overview of the current therapeutics and novel treatment strategies for patients diagnosed with BM from NSCLC.